|
[1] Vassalli J D, Sappino A P, Belin D. The plasminogen-activator plasmin system. Journal of Clinical Investigation, 1991, 88: 1067-1072.
[2] Sprengers E D, Kluft C. Plasminogen-activator inhibitors. Blood, 1987, 69: 381-387.
[3] Saksela O, Rifkin D B. Cell-associated plasminogen activation, regulation and physiological functions. Annual Review of Cell Biology, 1988, 4: 93-126.
[4] Plow E F, Herren T, Redlitz A, et al. The cell biology of the plasminogen system. Faseb Journal, 1995, 9: 939-945.
[5] Irigoyen J P, Munoz-Canoves P, Montero L, et al. The plasminogen activator system: Biology and regulation. Cellular and Molecular Life Sciences, 1999, 56: 104-132.
[6] Blomback G E B, Blomback M, Claeson K G, et al. New substrates for diagnostic use, with high susceptibility to thrombin and other proteolytic. United States, 3884896, 1975-05-20.
[7] Wilkesman J, Kurz L. Protease analysis by zymography: A review on techniques and patents. Recent Pat Biotechnol, 2009, 3: 175-184.
[8] Permin P M. Properties of the fibrinokinase-fibrinolysin system. Nature, 1947, 160: 571-572.
[9] Permin P M. The fibrinolytic activator in animal tissue. Acta Physiologica Scandinavica, 1950, 21: 159-167.
[10] Permin P M. 2 simple methods of determining fibrinolytic enzymes. Acta Physiologica Scandinavica, 1950, 20: 388-393.
[11] Astrup T, Mullertz S. The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics, 1952, 40: 346-351.
[12] Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta Physiologica Scandinavica, 1953, 27: 371-376.
[13] Walton P L. An improved fibrin plate method for assay of plasminogen activators. Clinica Chimica Acta, 1966, 13: 680-684.
[14] Barta G. Dyed fibrin plate assay of fibrinolysis. Canadian Journal of Physiology and Pharmacology, 1966, 44: 233-240.
[15] Kakinuma A, Tamura G, Arima K. Wetting of fibrin plate and apparent promotion of fibrinolysis by surfactin a new bacterial peptidelipid surfactant. Experientia, 1968, 24: 1120-1121.
[16] Edward N. Methods for improving sensitivity and specificity of fibrin plate. Journal of Clinical Pathology, 1972, 25: 335-337.
[17] Wijngaards G. Interfering factors in the assay of plasminogen activators by the fibrin plate method-occurrence of different inhibitors against tissue plasminogen activator and urokinase. Thrombosis and Haemostasis, 1979, 41: 590-600.
[18] Bishop R, Ekert H, Gilchris G, et al. Preparation and evaluation of a standardized fibrin plate for assessment of fibrinolytic activity. Thrombosis et Diathesis Haemorrhagica, 1970, 23: 202-210.
[19] Marsh N A, Arochapi C l. Evaluation of fibrin plate method for estimating plasminogen activators. Thrombosis et Diathesis Haemorrhagica, 1972, 28: 75-88.
[20] Marsh N A, Arochapi C l. Evaluation of original fibrin plate method for estimating plasminogen activators. Journal of Clinical Pathology, 1972, 25: 623-624.
[21] Haverkate F, Traas D W. Dose-response curves in fibrin plate assay fibrinolytic-activity of proteases. Thrombosis et Diathesis Haemorrhagica, 1974, 32: 356-365.
[22] Haverkate F, Brakman P. Fibrin plate assay-some crucial conditions. Thrombosis et Diathesis Haemorrhagica, 1975, 34: 312-313.
[23] Deogny L, Weidenbach A, Hampton J W. Improved fibrin plate method for fibrinolytic-activity measurements-use of bentonite precipitation and agar solidification. Clinica Chimica Acta, 1975, 60: 85-89.
[24] Marsh N A, Gaffney P J. Rapid fibrin plate-method for plasminogen activator assay. Thrombosis and Haemostasis, 1977, 38: 545-551.
[25] Jespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents-optimal conditions, reproducibility and precision. Haemostasis, 1983, 13: 301-315.
[26] Cliffton E E, Grossi C E. Fibrinolytic activity of human tumors as measured by the fibrin-plate method. Cancer, 1955, 8: 1146-1154.
[27] Denicola P, Soardi F. Fibrinolysis in liver diseases study of 109 cases by means of the fibrin plate method. Thrombosis et Diathesis Haemorrhagica, 1958, 2: 290-299.
[28] Nachlas M M, Plapinger R E, Seligman A M. Role of some structural features of subtrates on trypsin activity. Archives of Biochemistry and Biophysics, 1964, 108: 266-274.
[29] Plapinge R E, Nachlas M M, Seligman M L, et al. Synthesis of chromogenic arginine derivatives as substrates for trypsin. Journal of Organic Chemistry, 1965, 30: 1781-1785.
[30] Claeson K G, Karlsson B G, Svendsen L G. New substrates for diagnostic use, with high susceptibility to trypsin and other proteolytic enzymes of the type peptide peptidohydrolases. United States, 3886136 1975.
[31] Svendsen L G. Substrate for the quantitative determination of enzymes. United States, 4016042, 1977.
[32] Aurell L E, Claeson K G. Chromogenic enzyme substrates. United States, 4028318, 1977.
[33] Af Ekenstam B T, Aurell L E, Claeson K G, et al, Novel chromogenic thrombin substrates. United States, 4061625, 1977.
[34] Svendsen L G. Substrate for the quantitative determination of proteolytic enzymes. United States, 4070245, 1978.
[35] Svendsen L G. Substrate for the quantitative determination of plasminogen activators. United States, 4190574, 1980.
[36] Af Ekenstam B T, Aurell L E, Claeson K G, et al. Assay of serine proteases using novel chromogenic enzyme substrates. United States, 4214049, 1980.
[37] Svendsen L G, Method for the quantitative determination of plasminogen activators. United States, 4278762, 1981.
[38] Paar D, Maruhn D. Spectrometric determination of urokinase in urine after gel-filtration, using the chromogenic substrate s-2444. Journal of Clinical Chemistry and Clinical Biochemistry, 1980, 18: 557-562.
[39] Millar W T, Smith J F B. Comparative-study of different urokinase preparations. Thrombosis Research, 1983, 30: 425-429.
[40] Kuwada M, Katayama K. Differentiation of endopeptidases and aminopeptidases by high-performance liquid-chromatography of reaction-products from chromogenic peptide p-nitroanilines as substrates. Analytical Biochemistry, 1984, 139: 438-443.
[41] Higazi A A, Mayer M. In vitro inhibition of urokinase by penicillins. Thrombosis and Haemostasis, 1988, 60: 305-307.
[42] Hoem N O, Johannesen S, Briseid K. Assay of factor-xii in human-plasma using prekallikrein or the chromogenic peptide s-2222 as substrates-significance of the functional-state of plasma kallikrein. Thrombosis Research, 1989, 54: 197-205.
[43] Yoshida D, Watanabe K, Noha M, et al. Suppression of matrix metalloproteinase activity by si-27: Detection by a new activity assay with s-2444, a specific chromogenic peptide. Journal of Neuro-Oncology, 2002, 58: 1-11.
[44] Granellipiperno A, Reich E. Study of proteases and protease-inhibitor complexes in biological-fluids. Journal of Experimental Medicine, 1978, 148: 223-234.
[45] Erickson L A, Lawrence D A, Loskutoff D J. Reverse fibrin autography-a method to detect and partially characterize protease inhibitors after sodium dodecyl-sulfate polyacrylamide-gel electrophoresis. Analytical Biochemistry, 1984, 137: 454-463.
[46] Brunner G, Schirrmacher V. Fibrin autography of plasminogen-activator by electrophoretic transfer into fibrin agar gels. Analytical Biochemistry, 1988, 168: 411-416.
[47] Sprengers E D, Verheijen J H, Vanhinsbergh V W M, et al. Evidence for the presence of 2 different fibrinolytic inhibitors in human-endothelial cell conditioned medium. Biochimica et Biophysica Acta, 1984, 801: 163-170.
[48] Loskutoff D J, Schleef R R. Plasminogen activators and their inhibitors. Methods in Enzymology, 1988, 163: 293-302.
[49] Ong K L, Chang F N. Analysis of proteins from different phase variants of the entomopathogenic bacteria photorhabdus luminescens by two-dimensional zymography. Electrophoresis, 1997, 18: 834-839.
[50] Park S G, Kho C W, Cho S, et al. A functional proteomic analysis of secreted fibrinolytic enzymes from Bacillus subtilis 168 using a combined method of two-dimensional gel electrophoresis and zymography. Proteomics, 2002, 2: 206-211.
[51] Choi N S, Yoo K H, Yoon K S, et al. Nano-scale proteomics approach using two-dimensional fibrin zymography combined with fluorescent sypro ruby dye. Journal of Biochemistry and Molecular Biology, 2004, 37: 298-303.
[52] Lodemel J B, Egge-Jacobsen W, Olsen R L. Detection of timp-2-like protein in atlantic cod (Gadus morhua) muscle using two-dimensional real-time reverse zymography. Comparative Biochemistry and Physiology B-Biochemistry & Molecular Biology, 2004, 139: 253-259.
[53] Frederiks W M, Mook O R F. Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: Review and protocols. Journal of Histochemistry & Cytochemistry, 2004, 52: 711-722.
[54] Yan S J, Blomme E A G. In situ zymography: A molecular pathology technique to localize endogenous protease activity in tissue sections. Veterinary Pathology, 2003, 40: 227-236.
|
